Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review
- PMID: 30191087
- PMCID: PMC6125739
- DOI: 10.7916/D8FF58Z9
Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review
Abstract
Background: Although tardive dyskinesia (TD) is most commonly defined as a movement disorder caused by chronic exposure to dopamine-receptor-blocking drugs (DRBDs), it has also been thought to result from exposure to some non-DRBDs.
Methods: We critiqued many reviews making the association between non-DRBDs and a TD-like syndrome and almost all case reports. We checked whether cases met criteria for the diagnosis of TD-like syndrome and whether DRBDs had been excluded.
Results: We found that both tricyclic antidepressants and selective serotonin reuptake inhibitor antidepressants may unmask or exacerbate TD after prior exposure to or with concurrent use of DRBDs. We found support for its existence outside of this context to be extremely weak.
Discussion: There is little evidence that drugs other than DRBDs by themselves cause a TD syndrome; most reported cases appear to occur as a result of a "priming" effect induced by a DRBD, which is later unmasked.
Keywords: Anticholinergics; Antidepressants; Antiepileptics; Antihistamine; Non-dopamine receptor antagonists; Tardive Dyskinesia.
Conflict of interest statement
Funding: None. Conflict of Interests: Paid consultant to Acadia Pharmaceuticals; royalties from Springer and Cambridge University Presses; research funding from NIH and MJ Fox Foundation. Ethics Statement: This study was reviewed by the authors' institutional ethics committee and was considered exempted from further review.
Comment in
-
Reply to: Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review.Tremor Other Hyperkinet Mov (N Y). 2019 Feb 13;9:626. doi: 10.7916/3rez-p096. eCollection 2019. Tremor Other Hyperkinet Mov (N Y). 2019. PMID: 30783553 Free PMC article.
-
Response to Letter to the Editor.Tremor Other Hyperkinet Mov (N Y). 2019 Feb 6;9:630. doi: 10.7916/0rjw-cv10. eCollection 2019. Tremor Other Hyperkinet Mov (N Y). 2019. PMID: 30783554 Free PMC article.
Similar articles
-
Tardive dyskinesia and withdrawal emergent syndrome in children.Expert Rev Neurother. 2010 Jun;10(6):893-901. doi: 10.1586/ern.10.58. Expert Rev Neurother. 2010. PMID: 20518606 Review.
-
Reply to: Tardive Dyskinesia-like Syndrome Due to Drugs that do not Block Dopamine Receptors: Rare or Non-existent: Literature Review.Tremor Other Hyperkinet Mov (N Y). 2019 Feb 13;9:626. doi: 10.7916/3rez-p096. eCollection 2019. Tremor Other Hyperkinet Mov (N Y). 2019. PMID: 30783553 Free PMC article.
-
Pharmacotherapy for the treatment of tardive dyskinesia in schizophrenia patients.Expert Opin Pharmacother. 2017 Jul;18(10):965-972. doi: 10.1080/14656566.2017.1323874. Epub 2017 May 8. Expert Opin Pharmacother. 2017. PMID: 28443349
-
[Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].Encephale. 2016 Jun;42(3):248-54. doi: 10.1016/j.encep.2015.12.021. Epub 2016 Feb 26. Encephale. 2016. PMID: 26922134 Review. French.
-
Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs.Neuroscience. 2017 Oct 11;361:43-57. doi: 10.1016/j.neuroscience.2017.07.068. Epub 2017 Aug 5. Neuroscience. 2017. PMID: 28790021
Cited by
-
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.CNS Spectr. 2022 Apr;27(2):208-217. doi: 10.1017/S109285292000200X. Epub 2020 Nov 20. CNS Spectr. 2022. PMID: 33213556 Free PMC article. Review.
-
Tardive Dyskinesia Following Low-Dose Risperidone.Cureus. 2022 Dec 8;14(12):e32319. doi: 10.7759/cureus.32319. eCollection 2022 Dec. Cureus. 2022. PMID: 36628029 Free PMC article.
-
Treatable Hyperkinetic Movement Disorders Not to Be Missed.Front Neurol. 2021 Dec 1;12:659805. doi: 10.3389/fneur.2021.659805. eCollection 2021. Front Neurol. 2021. PMID: 34925200 Free PMC article. Review.
-
Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.Tremor Other Hyperkinet Mov (N Y). 2020 Oct 26;10:48. doi: 10.5334/tohm.554. Tremor Other Hyperkinet Mov (N Y). 2020. PMID: 33178486 Free PMC article.
-
Current perspectives on the epidemiology and burden of tardive dyskinesia: a focused review of the clinical situation in Japan.Ther Adv Psychopharmacol. 2022 Dec 26;12:20451253221139608. doi: 10.1177/20451253221139608. eCollection 2022. Ther Adv Psychopharmacol. 2022. PMID: 36601351 Free PMC article. Review.
References
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders (5th ed.) Arlington, VA: American Psychiatric Publishing; 2013.
-
- Wain OJ J. Tardive dyskinesia. In: Roos RP, editor. Neurology. San Diego: MedLink Corporation; 2017. editor. Available at wwwmedlinkcom, last updated February 27.
-
- Clayton AH. Antidepressant-induced tardive dyskinesia: review and case report. Psychopharmacol Bull. 1995;31:259–264. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous